Insider Transactions in Q2 2023 at Silverback Therapeutics, Inc. (SBTX)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 02
2023
|
Laura Shawver |
SELL
Open market or private sale
|
Direct |
26,941
-11.35%
|
$161,646
$6.95 P/Share
|
|
Jun 02
2023
|
Laura Shawver |
BUY
Exercise of conversion of derivative security
|
Direct |
26,941
+10.2%
|
$26,941
$1.27 P/Share
|
|
Jun 01
2023
|
Laura Shawver |
SELL
Open market or private sale
|
Direct |
73,059
-25.78%
|
$438,354
$6.8 P/Share
|
|
Jun 01
2023
|
Laura Shawver |
BUY
Exercise of conversion of derivative security
|
Direct |
73,059
+20.5%
|
$73,059
$1.27 P/Share
|
|
May 17
2023
|
Richard E Lowenthal PRESIDENT AND CEO |
BUY
Bona fide gift
|
Indirect |
2,100,000
+41.67%
|
-
|
|
May 17
2023
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Bona fide gift
|
Indirect |
1,050,000
-24.27%
|
-
|
|
May 17
2023
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Bona fide gift
|
Direct |
1,050,000
-20.28%
|
-
|
|
May 17
2023
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
BUY
Bona fide gift
|
Indirect |
2,100,000
+41.67%
|
-
|
|
May 17
2023
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Bona fide gift
|
Indirect |
1,050,000
-20.28%
|
-
|
|
May 17
2023
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Bona fide gift
|
Direct |
1,050,000
-24.27%
|
-
|
|
May 09
2023
|
Laura Shawver |
SELL
Open market or private sale
|
Direct |
42,900
-16.94%
|
$214,500
$5.31 P/Share
|
|
May 09
2023
|
Laura Shawver |
BUY
Exercise of conversion of derivative security
|
Direct |
42,900
+14.49%
|
$42,900
$1.27 P/Share
|
|
May 08
2023
|
Laura Shawver |
SELL
Open market or private sale
|
Direct |
57,100
-21.35%
|
$342,600
$6.16 P/Share
|
|
May 08
2023
|
Laura Shawver |
BUY
Exercise of conversion of derivative security
|
Direct |
57,100
+17.59%
|
$57,100
$1.27 P/Share
|